| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 7 |
| 1 | MELPHALAN HYDROCHLORIDE | 6 |
| 2 | PREDNISOLONE | 6 |
| 3 | PREDNISOLONE ORAL | 6 |
| 4 | PREDNISOLONE ORAL SOLUTION | 6 |
| 5 | PREDNISONE | 6 |
| 6 | OXALIPLATIN | 5 |
| 7 | FULVESTRANT | 4 |
| 8 | METRONIDAZOLE | 4 |
| 9 | METRONIDAZOLE TOPICAL | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ONASEMNOGENE ABEPARVOVEC-XIOI | 4 | 0.0017 |
| 1 | DAPRODUSTAT | 1 | 0.0005 |
| 2 | ALECTINIB HYDROCHLORIDE | 2 | 0.0003 |
| 3 | MELPHALAN HYDROCHLORIDE | 6 | 0.0002 |
| 4 | BELATACEPT | 1 | 0.0002 |
| 5 | ISATUXIMAB | 1 | 0.0002 |
| 6 | ROSUVASTATIN CALCIUM | 4 | 0.0001 |
| 7 | FULVESTRANT | 4 | 0.0001 |
| 8 | ABACAVIR SULFATE | 1 | 0.0001 |
| 9 | PITAVASTATIN CALCIUM | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 3 | Estrogen Receptor Antagonist [EPC] | 4 | 0.0001 |
| 4 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 3 | 0.0001 |
| 6 | Nitroimidazole Antimicrobial [EPC] | 4 | 0.0001 |
| 7 | Complement Inhibitor [EPC] | 3 | 0.0001 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |